Top-News

TC BioPharm Aktie (ADR) News

Aktie
WKN:  A411JQ ISIN:  US87807D6085 US-Symbol:  TCBPY Branche:  Biotechnologie Land:  Großbritannien
0,16 $
-0,0016 $
-0,99%
0,13736 € 04.12.25
Depot/Watchlist
Marktkapitalisierung *
91,13 Tsd. €
Streubesitz
-
KGV
-
Faktor
0.00025
Originalaktie
GB00BQD0NT81

TC BioPharm Aktie (ADR) News

09.04.25 - PR Newswire
TCBP Announces Grant of European Patent for Targeting of Microbial, Oncological, and Viral Indications using Modified Gamma Delta T Cells
TCBP Announces Grant of European Patent for Targeting of Microbial, Oncological, and Viral Indications using Modified Gamma Delta T Cells PR Newswire
21.03.25 - PR Newswire
TCBP Announces Transition from Nasdaq to OTC Markets
TCBP Announces Transition from Nasdaq to OTC Markets PR Newswire
18.03.25 - PR Newswire
TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead
TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead PR Newswire
05.03.25 - PR Newswire
TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company
TCBP Announces Non-​Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company PR Newswire
20.02.25 - PR Newswire
TCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO Forum
TCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO Forum PR Newswire
13.02.25 - PR Newswire
TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial
TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial PR Newswire
10.02.25 - PR Newswire
TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical Trial
TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical Trial PR Newswire
05.02.25 - PR Newswire
TCBP to Implement ADS Ratio Change
TCBP to Implement ADS Ratio Change PR Newswire
13.01.25 - PR Newswire
TCBP to Present at Sequire Investor Summit 2025
TCBP to Present at Sequire Investor Summit 2025 PR Newswire
06.01.25 - PR Newswire
TCBP Trading Continues Unabated on Nasdaq Stock Exchange
TCBP Trading Continues Unabated on Nasdaq Stock Exchange PR Newswire
31.12.24 - PR Newswire
TCBP Provides Update on Acquisition Strategy and Current Targets
TCBP Provides Update on Acquisition Strategy and Current Targets PR Newswire
30.12.24 - PR Newswire
/C O R R E C T I O N -- TC BioPharm/
/C O R R E C T I O N -- TC BioPharm/ PR Newswire
20.12.24 - PR Newswire
TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients
TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients PR Newswire
18.12.24 - PR Newswire
TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend
TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend PR Newswire
11.12.24 - PR Newswire
TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy
TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +1,03%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »